Related Experiment Videos
Analysis of HLA class II polymorphism using polymerase chain reaction
H Erlich1, T Bugawan, A Begovich
1Department of Human Genetics, Roche Molecular Systems Inc, Alameda, Calif. 94501.
Archives of Pathology & Laboratory Medicine
|May 1, 1993
Summary
A new method for Human Leukocyte Antigen (HLA) class II typing using polymerase chain reaction (PCR) and oligonucleotide probes offers enhanced precision for disease susceptibility and transplantation. This DNA-based approach identifies more alleles than traditional serologic methods, improving donor-recipient matching and genetic predisposition studies.
Area of Science:
- Immunogenetics
- Molecular Biology
- Human Genetics
Background:
- Human Leukocyte Antigen (HLA) class II typing is crucial for disease susceptibility, transplantation, and anthropological studies.
- Conventional serologic typing methods have limitations in distinguishing the full spectrum of HLA class II polymorphism.
- A need exists for a more precise and comprehensive method to analyze HLA class II variations.
Purpose of the Study:
- To describe a novel method for analyzing HLA class II sequence polymorphism.
- To enhance the accuracy and resolution of HLA class II typing beyond conventional serologic techniques.
- To facilitate improved donor-recipient matching in transplantation and identification of disease-associated alleles.
Main Methods:
- Utilizing polymerase chain reaction (PCR) for amplification of HLA class II loci.
- Employing hybridization with sequence-specific oligonucleotide probes for allele discrimination.
- Analyzing polymorphisms at DRB1, DPB1, and DQB1 loci.
Main Results:
- The PCR/oligonucleotide probe method distinguishes significantly more alleles than serologic typing.
- This technique reveals the precise location and nature of allelic differences, aiding in disease association studies.
- The method successfully identified 7 DQ alpha 1, 15 DQ beta 1, 18 DPB1, and 32 DRB1 alleles.
Conclusions:
- The described PCR and oligonucleotide probe hybridization method provides a simple, rapid, and precise approach to HLA class II typing.
- This advanced typing strategy is expected to reduce graft rejection and graft-vs-host disease by improving donor-recipient matching.
- The method enhances the identification of genetic predispositions to diseases by distinguishing numerous subtypes within serologic types.